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Background	
Disease	activity	indices	(DAI)	are	used	to	guide	immunosuppressive	therapy	in	
rheumatoid	arthritis	(RA).	The	inclusion	of	patient	global	assessment	(PGA)	in	these	
indices	has	been	questioned	as	it	conveys	mainly	disease	impact	rather	than	disease	
activity.	
Objectives	
To	determine	the	influence	of	PGA	on	patient	disease	states	and	to	determine	PGA	
correlations	with	inflammatory	parameters,	disease	impact,	demographic,	clinical	
and	contextual	factors.	
Methods	
The	METEOR	international	database	was	used,	namely	data	from	patients'	first	
available	visit	with	no	missing	values	on	PGA,	tender	and	swollen	joint	counts	(TJC28,	
SJC28)	and	C-reactive	protein	(CRP).	Remission	rates	were	compared	according	to	
the	DAS28CRP3v	vs	4v	and	ACR/EULAR	Boolean	remission	vs	near-remission	(failing	1	
of	the	4	criteria)	definition.	We	assessed	the	correlation	of	PGA	with	(predominantly)	
inflammatory	(TJC28,	SJC28,	CRP)	and	disease	impact	(pain	and	HAQ)	factors.	We	
used	hierarchical	modelling	to	explain	PGA	by	4	blocks	(B)	of	independent	variables	
(B1:	gender,	age,	disease	duration;	B2:	biologic	DMARD,	Gross	National	Income;	B3:	
pain,	HAQ;	and	B4:	TJC28,	SJC28,	CRP).	
Results	
Among	the	18280	patients	analysed,	1930	(10.6%)	were	in	DAS28CRP4v	remission,	
and	2197	(12.0%)	in	DAS28CRP3v	remission.	According	to	the	Boolean	definition,	
1207	(6.6%)	patients	were	in	remission.	PGA	was	the	main	obstacle	to	Boolean	
remission:	2090	(79.0%)	of	the	2645	near-remission	patients	(Table	1).	A	
considerable	proportion	of	patients	with	low	inflammation	perceived	high	PGA	
(Figure	1).	
PGA	correlated	better	with	Pain	(rp=.79)	and	HAQ	(rp=.55)	than	with	TJC28	(rp=.45),	
SJC28	(rp=.36)	or	CRP	(rp=.25).	
In	the	entire	dataset,	60.2%	of	PGA	variance	was	explained	by	Pain	and	HAQ,	1.8%	by	
B1	and	B2	of	covariates	and	only	1.3%	by	B4	(TJC28,	SJC28,	CRP)	(Table	2).	In	near-
remission	patients,	B4	did	not	contribute	significantly	to	changes	in	the	model.	
Table	1.	Remission	and	near-remission	rates	(n=18280)	
	
	
Table	2.	Hierarchical	multivariable	regression	analysis	to	explain	PGA	
	
	
Figure	1.	PGA	distribution	in	patients	in	remission	by	DAS28CRP3v	(n=2197)	and	in	
PGA-near-remission	by	Boolean	definition	(n=2090)	
	
	
Conclusions	Two	thirds	of	patients	that	achieve	TJC28,	SJC28,	and	CRP≤1	still	
perceive	high	PGA	despite	disease	“inflammatory”	control.	The	weight	of	PGA	in	DAI	
could	lead	to	immunosuppressive	overtreatment.	In	these	patients,	disease	impact	
management,	including	non-pharmacological	treatments	delivered	by	Health	Care	
Professionals,	are	more	likely	to	be	effective.	
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